Home    Back

Srx246    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
8Huntington disease1

8. Huntington disease    [ 197 clinical trials,   171 drugs,   (DrugBank: 54 drugs),   82 drug target genes,   144 drug target pathways]
Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 197 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02507284
(ClinicalTrials.gov)		May 10, 201622/7/2015Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's DiseaseAn Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects With Huntington's Disease (HD)Irritable Mood;Huntington's DiseaseDrug: SRX246;Drug: PlaceboAzevan PharmaceuticalsNational Institute of Neurological Disorders and Stroke (NINDS);NeuroNEXT NetworkCompleted18 YearsN/AAll106Phase 2United States